Injection Site Reactions: Pain, redness, swelling, or tenderness at the site where the injection was given
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
Repeated freeze-thaw cycles are not recommended because they may reduce material quality
This makes the fragment a useful reference in studies designed to isolate lipolytic endpoints from GH-axis side effects
Key Features: Provides essential Vitamin B12 supplementation for animals
For more information, Contact us today or book an appointment online